Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer

doi:10.3748/wjg.v12.i35.5635

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2669)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series.

Item

Count

PDF

353

HTML

2154

Figures (1-7)

155

Sum=2662

Sep 21, 2006 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. Sep 21, 2006; 12(35): 5635-5643
Published online Sep 21, 2006. doi: 10.3748/wjg.v12.i35.5635

Full Size Figure Download Figure

Figure 6 Effects of NVP-AEW541 on the cell cycle of colorectal carcinoma cells (means ± SE, n = 4). After 24 h incubation with NVP-AEW541, a dose-dependent accumulation of HT-29 (A) and HCT-116 (B) cells was observed in the G0/G1 phase of the cell cycle (white bars). Proportion of cells in the S and G2/M phase (grey and black bars) decreased. ^aP < 0.05 vs untreated controls.

Citation: Höpfner M, Sutter AP, Huether A, Baradari V, Scherübl H. Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer. World J Gastroenterol 2006; 12(35): 5635-5643
URL: https://www.wjgnet.com/1007-9327/full/v12/i35/5635.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i35.5635